We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PRCT market cap is 3.28B. The company's latest EPS is USD -2.0779 and P/E is -30.91.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.35M | 23.78M | 24.4M | 33.1M | 35.1M |
| Operating Income | -22.11M | -25.04M | -28.38M | -25.63M | -25.61M |
| Net Income | -22.61M | -28.17M | -28.48M | -25.29M | -24.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.17M | 7.72M | 34.47M | 75.01M | 136.19M |
| Operating Income | -43.55M | -47.8M | -54.16M | -80.72M | -109.17M |
| Net Income | -41.98M | -53.02M | -59.85M | -87.15M | -105.9M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 324.04M | 309.33M | 284.46M | 272.45M | 421.13M |
| Total Liabilities | 103.28M | 112.26M | 111.33M | 116.54M | 121.77M |
| Total Equity | 220.76M | 197.07M | 173.13M | 155.9M | 299.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62M | 125.97M | 337.02M | 309.33M | 404.72M |
| Total Liabilities | 32.76M | 65.01M | 69.93M | 112.26M | 123.97M |
| Total Equity | -143.84M | -182.89M | 267.09M | 197.07M | 280.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -55.21M | -80.38M | -35.93M | -64.27M | -83.21M |
| Investing | -1.79M | -2.65M | -5.34M | -10.71M | -16.49M |
| Financing | 4.93M | 3.61M | 380k | 2.81M | 164.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -43.82M | -48.34M | -57.33M | -80.38M | -108M |
| Investing | 43.15M | -233k | -592k | -2.65M | -25.21M |
| Financing | 26.53M | 106.77M | 262.12M | 3.61M | 167.8M |
| Market Cap | 3.28B |
| Price to Earnings Ratio | -30.91 |
| Price to Sales Ratio | 24.04 |
| Price to Cash Ratio | 12.73 |
| Price to Book Ratio | 11.66 |
| Dividend Yield | - |
| Shares Outstanding | 50.96M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 662.49k |
| 52 Week Change | 124.78% |
| 52 Week High | 64.89 |
| 52 Week Low | 24.83 |
| Spread (Intraday) | 9.87 (14.03%) |
| Company Name | PROCEPT BioRobotics Corporation |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.procept-biorobotics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
